| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |